logo

Diffusion Pharmaceuticals Inc. ( (DFFN)



Trade DFFN now with
  Date
  Headline
10/19/2020 8:08:56 AM Diffusion Pharma Appoints Chris Galloway As Chief Medical Officer
9/10/2020 8:10:30 AM Diffusion Doses First Two Patients With TSC In COVID-19 Clinical Trial
7/27/2020 8:21:49 AM Diffusion Gets FDA Guidance For International Phase 1b/2b COVID-19 Clinical Program With TSC
6/1/2020 8:09:00 AM Diffusion Regains Compliance With NASDAQ Minimum Bid Price Requirement
5/26/2020 8:06:39 AM Diffusion Receives Accelerated Response From FDA To PIND Meeting Request
4/1/2020 8:15:59 AM Diffusion Evaluates Trans Sodium Crocetinate Against ARDS In COVID-19 Patients
2/7/2020 8:38:43 AM Diffusion Pharmaceuticals Secures European Patent Related Compositions Of TSC
7/23/2019 8:43:35 AM Diffusion Reports Favorable Safety Data For Dose-Escalation Run-in Of Phase 3 INTACT Study